Pfizer CEO Bourla Says Company Looking For ‘Superior’ Results from Weight-Loss Drugs

Pfizer CEO Albert Bourla told Bloomberg’s Katie Greifeld Pfizer is looking for ‘superior results’ while developing and testing further GLP-1 weight loss medications in a crowded market. Bourla also commented on his company’s relationship with the Trump administration as businesses look for stability on pricing and tariffs. He told Bloomberg he is optimistic that uncertainty around White House policy is ‘behind us.’ (Source: Bloomberg)